View Older Stories View More Recent Stories

Mar 7, 2025 10:21PM ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA

Mar 7, 2025 07:52AM Guggenheim Downgrades Neumora Therapeutics (NMRA) to Neutral

Mar 7, 2025 12:16AM Stifel Downgrades Neumora Therapeutics (NMRA) to Hold

Mar 5, 2025 05:18PM ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA

Mar 5, 2025 04:00PM NMRA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Neumora Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Mar 4, 2025 06:00PM NMRA INVESTOR ALERT: Kirby McInerney LLP Notifies Neumora Therapeutics, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit

Mar 4, 2025 05:13PM ROSEN, LEADING INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA

Mar 4, 2025 09:33AM ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Neumora Therapeutics

Mar 3, 2025 01:15PM Guggenheim Reiterates Buy Rating on Neumora Therapeutics (NMRA), PT $7

Mar 3, 2025 09:16AM Neumora Therapeutics (NMRA) PT Lowered to $6 at Stifel

Mar 3, 2025 07:07AM Neumora Therapeutics, Inc. (NMRA) Tops Q4 EPS by 25c

Mar 2, 2025 08:29PM ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA

Mar 1, 2025 08:29PM ROSEN, A LEADING LAW FIRM, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA

Feb 28, 2025 08:24PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA

Feb 28, 2025 01:54PM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Neumora Therapeutics

Feb 27, 2025 08:19PM ROSEN, SKILLED INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA

Feb 27, 2025 04:00PM NMRA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Neumora Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Feb 26, 2025 08:14PM ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA

Feb 25, 2025 08:09PM ROSEN, LEADING INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA

Feb 25, 2025 11:10AM NMRA INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Neumora Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit

Feb 24, 2025 08:04PM ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA

Feb 24, 2025 06:10PM ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Neumora Therapeutics

Feb 24, 2025 06:16AM Neumora Therapeutics (NMRA) PT Lowered to $4 at Mizuho

Feb 23, 2025 03:07PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA

Feb 22, 2025 08:20AM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Neumora Therapeutics

Feb 20, 2025 07:18PM ROSEN, LEADING INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA

Feb 20, 2025 04:00PM NMRA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Neumora Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Feb 19, 2025 07:13PM ROSEN, A LONGSTANDING FIRM, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA

Feb 18, 2025 08:19PM INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Neumora Therapeutics

Feb 18, 2025 07:07PM ROSEN, A LEADING LAW FIRM, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA

Feb 17, 2025 12:15PM NMRA INVESTOR DEADLINE: Neumora Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Feb 16, 2025 04:00PM NMRA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Neumora Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Feb 15, 2025 10:09PM ROSEN, NATIONAL TRIAL COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA

Feb 14, 2025 10:15PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA

Feb 14, 2025 09:52AM INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Neumora Therapeutics

Feb 13, 2025 10:10PM ROSEN, LEADING INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA

Feb 13, 2025 07:01AM Neumora Therapeutics (NMRA) Announces Leadership Transition

Feb 12, 2025 10:09PM ROSEN, SKILLED INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA

Feb 11, 2025 10:04PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA

Feb 11, 2025 08:18PM Faruqi & Faruqi Reminds Neumora Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 7. 2025 - NMRA

Feb 10, 2025 07:44PM SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Neumora Therapeutics

Feb 10, 2025 04:00PM NMRA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Neumora Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Feb 9, 2025 07:06PM ROSEN, A RANKED AND LEADING INVESTOR RIGHTS FIRM, Encourages Neumora Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - NMRA

Feb 9, 2025 09:10AM Faruqi & Faruqi Reminds Neumora Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 7. 2025 - NMRA

Jan 6, 2025 04:38AM Neumora Therapeutics (NMRA) PT Lowered to $7 at BofA Securities

Jan 3, 2025 06:36AM H.C. Wainwright Reiterates Buy Rating on Neumora Therapeutics (NMRA)

Jan 3, 2025 06:35AM Mizuho Reiterates Outperform Rating on Neumora Therapeutics (NMRA)

Jan 2, 2025 11:06AM RBC Capital Downgrades Neumora Therapeutics (NMRA) to Sector Perform

Jan 2, 2025 07:01AM Neumora Therapeutics (NMRA) Reports Data from KOASTAL-1 Study of Navacaprant

Jan 2, 2025 05:55AM Neumora Therapeutics (NMRA) call put ratio 1 call to 1 put on 17K contracts

View More Recent Stories View Older Stories